Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
2022 · Nature Communications · 62 citations
https://doi.org/10.1038/s41467-022-31035-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
947
Citations
8
h-index
8
i10-index
Amanda Heard is an academic researcher from The University of Kansas Cancer Center. The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses. The author has an h-index of 8, co-authored 19 publications.
ORCID: 0000-0002-7150-7998https://doi.org/10.1038/s41467-022-31035-7
https://doi.org/10.1136/jitc-2024-010179
Click to start Chat